Zimmer Biomet’s Dental And Spine Spin-Off Will Be Called ZimVie
Executive Summary
The company also named ZimVie’s management team, led by CEO Vafa Jamali.
You may also be interested in...
ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study
The US FDA has granted Investigational Device Exemption to Colorado life sciences company ZimVie for its cervical disc implant. The approval means the company can begin enrolling patients in a study to further evaluate the device.
Analysts Applaud Zimmer Biomet’s Dental And Spine Spin-Off, Focus On Orthopedics
Zimmer Biomet’s CEO Bryan Hanson expects the spin-off will help streamline the company and optimize resources for innovation.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.